Novavax | NVAX - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Adma Biologics USD 88.82M 13.19M 2025-12
Agenus USD 34.2M 4.61M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
Cassava Sciences USD -3.96M 1.16M 2025-09
Geron USD 46.71M 525K 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
MannKind USD 78.31M 76.21M 2025-12
Merck USD 10.85B 2.57B 2025-12
Minerva Neurosciences -4.27M 26.79M 2024-12
Moderna USD -566M 792M 2026-03
Novartis USD 10.82B 694M 2025-09
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
TG Therapeutics USD 154.43M 20.81M 2025-12